Aura Clinic Singapore
Injectable Skincare is a patented bio-remodelling injectable technology, serving as an “injectable skincare” solution. This innovative approach targets skin laxity and signs of aging by stimulating collagen, elastin, and adipocyte (fat) stem cells affected by the aging process. Boasting Stabilized Hybrid Cooperative Complexes (HCC) of high and low molecular weight Ultrapure Hyaluronic Acid in a concentrated form, Injectable Skincare employs the exclusive NAHYCO® Technology—a unique thermal production process patented by IBSA. It was approved by Health Sciences Authority of Singapore on 17 July 2020 as an injectable treatment to reverse physiological process of skin ageing and reduced hydration by altering the elastic fibers and remodels the collagen in the dermis.
In the realm of in-clinic treatments, Injectable Skincare BODY mirrors the ingredients of Injectable Skincare but comes in a larger 3ml syringe. Specifically designed for comprehensive body treatment, it addresses skin laxity concerns.
The corrective action of Injectable Skincare BODY enhances skin hydration, revitalizes elastic fibers, rebuilds collagen structure in the dermis, and supports the dermal tissue repair process, ultimately improving skin laxity.
Key Benefits of Injectable Skincare BODY:
Note: Please note that the Ministry of Health of Singapore prohibits the publication of before-and-after photos and patient testimonials in advertising materials. To learn more about this treatment, visit our clinics, where we can provide additional photographs and patient images.